Hélène D.
- Country
- France
- Department
- hématologie
Research Overview
- Efficacy and Safety of Etentamig and Daratumumab Versus Daratumumab and Combination Therapy in Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma
- Phase 2, multicenter, open‑label study of extended‑dosing belantamab mafodotin in combination therapy for relapsed/refractory multiple myeloma
- Phase 3 Study of Isatuximab, Lenalidomide, and Dexamethasone ± Bortezomib in Non-Frail, Transplant-Ineligible Elderly Patients with Newly Diagnosed Multiple Myeloma
Data & Insights
Has run more than one trial at 91 of 207 partner sites.
Specializations
Multiple Myeloma Treatment Innovations
This investigator specializes in pioneering research focused on novel therapeutic approaches for multiple myeloma, with particular emphasis on treatment strategies for newly diagnosed patients.
- Minimal Residual Disease (MRD) adapted therapies
- Autologous stem cell transplantation approaches
- Innovative combination therapies
Their work encompasses both transplant-eligible and ineligible patient populations.
Elderly Patient Care
The investigator demonstrates significant expertise in developing treatment protocols for elderly multiple myeloma patients, focusing on non-frail transplant-ineligible individuals aged 65-80 years.
- Age-adapted treatment strategies
- Novel agent combinations for elderly patients
- Frailty-considerate therapeutic approaches
Their research emphasizes optimizing treatment outcomes while considering age-specific factors.
Advanced Therapeutic Development
The investigator leads research in emerging multiple myeloma treatments, particularly focusing on monoclonal antibody therapies and innovative drug combinations.
- Bispecific antibody applications
- Immunotherapy approaches
- Combination therapy optimization
Their work includes evaluation of both subcutaneous and traditional administration methods.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.